Wednesday Jul 16
Applied Clinical Trials
Rigel Initiates Phase 3 Studies of Fostamatinib in ITP
The focus of these clinical studies is to evaluate the potential of fostamatinib to increase the platelet counts of patients with chronic ITP.
Unusual Call Options Trade in Rigel Pharmaceuticals
One trader has high expectations on Rigel Pharmaceuticals stock price over the coming months.
Virobay Inc. Announces The Appointment Of As Chief Financial Officer
Prior to joining Virobay, Mr. Welch was Chief Financial Officer at AcelRx Pharmaceuticals, a publicly held pharmaceutical company dedicated to the development and commercialization of innovative products for the treatment of painful conditions.
Rigel Pharmaceuticals, Inc. To Present At Jefferies and Co. 2014 Global Healthcare Conference
Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.